Literature DB >> 8093014

The effect of elevated plasma phenylalanine levels on protein synthesis rates in adult rat brain.

D S Dunlop1, X R Yang, A Lajtha.   

Abstract

Increasing the plasma phenylalanine concentration to levels as high as 0.560-0.870 mM (over ten times normal levels) had no detectable effect on the rate of brain protein synthesis in adult rats. The average rates for 7-week-old rats were: valine, 0.58 +/- 0.05%/h, phenylalanine, 0.59 +/- 0.06%/h, and tyrosine, 0.60 +/- 0.09%/h, or 0.59 +/- 0.06%/h overall. Synthesis rates calculated on the basis of the specific activity of the tRNA-bound amino acid were slightly lower (4% lower for phenylalanine) than those based on the brain free amino acid pool. Similarly, the specific activities of valine and phenylalanine in microdialysis fluid from striatum were practically the same as those in the brain free amino acid pool. Thus the specific activities of the valine and phenylalanine brain free pools are good measures of the precursor specific activity for protein synthesis. In any event, synthesis rates, whether based on the specific activities of the amino acids in the brain free pool or those bound to tRNA, were unaffected by elevated levels of plasma phenylalanine. Brain protein synthesis rates measured after the administration of quite large doses of phenylalanine (> 1.5 mumol/g) or valine (15 mumol/g) were in agreement (0.62 +/- 0.01 and 0.65 +/- 0.01%/h respectively) with the rates determined with infusions of trace amounts of amino acids. Thus the technique of stabilizing precursor-specific activity, and pushing values in the brain close to those of the plasma, by the administration of large quantities of precursor, appears to be valid.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8093014      PMCID: PMC1137270          DOI: 10.1042/bj3020601

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Brain uptake and protein incorporation of amino acids studied in rats subjected to prolonged hyperphenylalaninaemia.

Authors:  K N Antonas; W F Coulson
Journal:  J Neurochem       Date:  1975-09       Impact factor: 5.372

2.  A method for measuring brain protein synthesis rates in young and adult rats.

Authors:  D S Dunlop; W van Elden; A Lajtha
Journal:  J Neurochem       Date:  1975-02       Impact factor: 5.372

3.  Optimal conditions for protein synthesis in incubated slices of rat brain.

Authors:  D S Dunlop; W van Elden; A Lajtha
Journal:  Brain Res       Date:  1975-12-05       Impact factor: 3.252

4.  A technique for measuring brain protein synthesis.

Authors:  P J Garlick; I Marshall
Journal:  J Neurochem       Date:  1972-03       Impact factor: 5.372

5.  Hyperphenylalaninemia: disaggregation of brain polyribosomes in young rats.

Authors:  K Aoki; F L Siegel
Journal:  Science       Date:  1970-04-03       Impact factor: 47.728

6.  Hyperphenylalanemia: effect on brain polyribosomes can be partially reversed by other amino acids.

Authors:  J V Hughes; T C Johnson
Journal:  Science       Date:  1977-01-28       Impact factor: 47.728

7.  Analysis of the specific radioactivity of valine isolated from aminoacyl-transfer ribonucleic acid of rat liver.

Authors:  C S Wallyn; A Vidrich; J Airhart; E A Khairallah
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

8.  Brain succinate semialdehyde. II. Changes in the developing rat brain.

Authors:  F N Pitts; C Quick
Journal:  J Neurochem       Date:  1967-05       Impact factor: 5.372

9.  Effect of phenylalanine on protein synthesis in the developing rat brain.

Authors:  H C Agrawal; A H Bone; A N Davison
Journal:  Biochem J       Date:  1970-04       Impact factor: 3.857

10.  O-phthalaldehyde: fluorogenic detection of primary amines in the picomole range. Comparison with fluorescamine and ninhydrin.

Authors:  J R Benson; P E Hare
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

View more
  9 in total

1.  Differences between males and females in rates of serotonin synthesis in human brain.

Authors:  S Nishizawa; C Benkelfat; S N Young; M Leyton; S Mzengeza; C de Montigny; P Blier; M Diksic
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

2.  On the way to commercializing plant cell culture platform for biopharmaceuticals: present status and prospect.

Authors:  Jianfeng Xu; Ningning Zhang
Journal:  Pharm Bioprocess       Date:  2014-12-01

3.  Cerebral protein synthesis in a genetic mouse model of phenylketonuria.

Authors:  C B Smith; J Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

Review 4.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

5.  Use of acute hyperphenylalaninemia in rhesus monkeys to examine sensitivity and stability of the L-[1-11C]leucine method for measurement of regional rates of cerebral protein synthesis with PET.

Authors:  Carolyn B Smith; Kathleen C Schmidt; Shrinivas Bishu; Michael A Channing; Jeff Bacon; Thomas V Burlin; Mei Qin; Zhong-Hua Liu; Zengyan Xia; Tianjiang Huang; Bee-Kee Vuong; Peter Herscovitch
Journal:  J Cereb Blood Flow Metab       Date:  2008-04-23       Impact factor: 6.200

Review 6.  Non-signalling energy use in the brain.

Authors:  Elisabeth Engl; David Attwell
Journal:  J Physiol       Date:  2015-03-11       Impact factor: 5.182

Review 7.  The Isolated Brain Microvessel: A Versatile Experimental Model of the Blood-Brain Barrier.

Authors:  William M Pardridge
Journal:  Front Physiol       Date:  2020-05-07       Impact factor: 4.566

8.  Bi-functional IgG-lysosomal enzyme fusion proteins for brain drug delivery.

Authors:  Ruben J Boado; Jeff Zhiqiang Lu; Eric Ka-Wai Hui; Huilan Lin; William M Pardridge
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379

9.  Insulin receptor antibody-sulfamidase fusion protein penetrates the primate blood-brain barrier and reduces glycosoaminoglycans in Sanfilippo type A cells.

Authors:  Ruben J Boado; Jeff Zhiqiang Lu; Eric Ka-Wai Hui; William M Pardridge
Journal:  Mol Pharm       Date:  2014-06-26       Impact factor: 4.939

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.